BenevolentAI is a clinical-stage AI-enabled drug discovery company. It offers an AI platform, scientific expertise, and wet-lab facilities. The Benevolent Platform powers a growing in-house pipeline of 20+ disease programs and maintains collaborations with other drug discovery companies and research and charitable institutions.